Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection.
Diamantopoulos PT, Kontandreopoulou CN, Stafylidis C, Vlachopoulou D, Giannakopoulou N, Vardaka M, Mpouhla A, Variami E, Galanopoulos A, Pappa V, Psichogiou M, Hatzakis A, Viniou NA.
Diamantopoulos PT, et al. Among authors: hatzakis a.
Ann Hematol. 2022 Dec;101(12):2711-2717. doi: 10.1007/s00277-022-05003-6. Epub 2022 Oct 22.
Ann Hematol. 2022.
PMID: 36271935
Free PMC article.